Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell

Xiang Dong He, Zhi Ping Wang, Hai Yan Wei, Qin Zhou, De Gui Wang, Jun Qiang Tian, Sheng Jun Fu, Ronald Rodriguez

Research output: Contribution to journalArticle

Abstract

Aim: To construct urothelium-specific recombinant adenovirus and investigate its inhibition in bladder cancer cell. Methods: RT-PCR analysis was used to determine expression patterns of hUPII and coxsackie adenovirus receptor on multiple cell lines. Transient transfection and luciferase detecting assay were used to detect tissue specificity of the hUPII promoter. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed. Restrictive enzyme digestion assay and PCR confirmed the correct construction. The adenovirus E1A protein expressed in BIU-87 was tested by Western blot after cells were infected with recombinant adenovirus. Recombinant adenovirus Ad-UPII-E1A was tested for its inhibition in bladder cancer cell line BIU-87. Results: HUPII and CAR were expressed and the hUPII promoter is highly active in bladder cancer cell line BIU-87. Using homologous recombination in bacteria technology, the hUPII promoter and E1A gene were inserted into the genome of type 5 recombinant adenovirus. The E1A protein was markedly positive in the samples of BIU-87 cells infected with recombinant adenovirus Ad-UPII-E1A. MTT assay demonstrated recombinant adenovirus Ad-UPII-E1A inhibited bladder cancer cell BIU-87 growth. Conclusion: The hUPII promoter shows high tissue specificity. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed and confirmed. Recombinant adenovirus Ad-UPII-E1A is effective in inhibition in bladder cancer cell line BIU-87.

Original languageEnglish (US)
Pages (from-to)209-213
Number of pages5
JournalUrologia Internationalis
Volume82
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Urothelium
Urinary Bladder Neoplasms
Adenoviridae
Cell Line
Organ Specificity
Adenovirus E1A Proteins
Coxsackie and Adenovirus Receptor-Like Membrane Protein
Polymerase Chain Reaction
Homologous Recombination
Enzyme Assays
Luciferases
Transfection
Digestion
Western Blotting
Genome
Technology
Bacteria

Keywords

  • Bladder cancer cell line
  • Gene therapy
  • Human uroplakin II
  • Recombinant adenovirus

ASJC Scopus subject areas

  • Urology

Cite this

He, X. D., Wang, Z. P., Wei, H. Y., Zhou, Q., Wang, D. G., Tian, J. Q., ... Rodriguez, R. (2009). Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell. Urologia Internationalis, 82(2), 209-213. https://doi.org/10.1159/000200802

Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell. / He, Xiang Dong; Wang, Zhi Ping; Wei, Hai Yan; Zhou, Qin; Wang, De Gui; Tian, Jun Qiang; Fu, Sheng Jun; Rodriguez, Ronald.

In: Urologia Internationalis, Vol. 82, No. 2, 03.2009, p. 209-213.

Research output: Contribution to journalArticle

He, XD, Wang, ZP, Wei, HY, Zhou, Q, Wang, DG, Tian, JQ, Fu, SJ & Rodriguez, R 2009, 'Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell', Urologia Internationalis, vol. 82, no. 2, pp. 209-213. https://doi.org/10.1159/000200802
He, Xiang Dong ; Wang, Zhi Ping ; Wei, Hai Yan ; Zhou, Qin ; Wang, De Gui ; Tian, Jun Qiang ; Fu, Sheng Jun ; Rodriguez, Ronald. / Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell. In: Urologia Internationalis. 2009 ; Vol. 82, No. 2. pp. 209-213.
@article{5c9cc2880bd949fbb91106f9e3d0af68,
title = "Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell",
abstract = "Aim: To construct urothelium-specific recombinant adenovirus and investigate its inhibition in bladder cancer cell. Methods: RT-PCR analysis was used to determine expression patterns of hUPII and coxsackie adenovirus receptor on multiple cell lines. Transient transfection and luciferase detecting assay were used to detect tissue specificity of the hUPII promoter. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed. Restrictive enzyme digestion assay and PCR confirmed the correct construction. The adenovirus E1A protein expressed in BIU-87 was tested by Western blot after cells were infected with recombinant adenovirus. Recombinant adenovirus Ad-UPII-E1A was tested for its inhibition in bladder cancer cell line BIU-87. Results: HUPII and CAR were expressed and the hUPII promoter is highly active in bladder cancer cell line BIU-87. Using homologous recombination in bacteria technology, the hUPII promoter and E1A gene were inserted into the genome of type 5 recombinant adenovirus. The E1A protein was markedly positive in the samples of BIU-87 cells infected with recombinant adenovirus Ad-UPII-E1A. MTT assay demonstrated recombinant adenovirus Ad-UPII-E1A inhibited bladder cancer cell BIU-87 growth. Conclusion: The hUPII promoter shows high tissue specificity. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed and confirmed. Recombinant adenovirus Ad-UPII-E1A is effective in inhibition in bladder cancer cell line BIU-87.",
keywords = "Bladder cancer cell line, Gene therapy, Human uroplakin II, Recombinant adenovirus",
author = "He, {Xiang Dong} and Wang, {Zhi Ping} and Wei, {Hai Yan} and Qin Zhou and Wang, {De Gui} and Tian, {Jun Qiang} and Fu, {Sheng Jun} and Ronald Rodriguez",
year = "2009",
month = "3",
doi = "10.1159/000200802",
language = "English (US)",
volume = "82",
pages = "209--213",
journal = "Urologia Internationalis",
issn = "0042-1138",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell

AU - He, Xiang Dong

AU - Wang, Zhi Ping

AU - Wei, Hai Yan

AU - Zhou, Qin

AU - Wang, De Gui

AU - Tian, Jun Qiang

AU - Fu, Sheng Jun

AU - Rodriguez, Ronald

PY - 2009/3

Y1 - 2009/3

N2 - Aim: To construct urothelium-specific recombinant adenovirus and investigate its inhibition in bladder cancer cell. Methods: RT-PCR analysis was used to determine expression patterns of hUPII and coxsackie adenovirus receptor on multiple cell lines. Transient transfection and luciferase detecting assay were used to detect tissue specificity of the hUPII promoter. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed. Restrictive enzyme digestion assay and PCR confirmed the correct construction. The adenovirus E1A protein expressed in BIU-87 was tested by Western blot after cells were infected with recombinant adenovirus. Recombinant adenovirus Ad-UPII-E1A was tested for its inhibition in bladder cancer cell line BIU-87. Results: HUPII and CAR were expressed and the hUPII promoter is highly active in bladder cancer cell line BIU-87. Using homologous recombination in bacteria technology, the hUPII promoter and E1A gene were inserted into the genome of type 5 recombinant adenovirus. The E1A protein was markedly positive in the samples of BIU-87 cells infected with recombinant adenovirus Ad-UPII-E1A. MTT assay demonstrated recombinant adenovirus Ad-UPII-E1A inhibited bladder cancer cell BIU-87 growth. Conclusion: The hUPII promoter shows high tissue specificity. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed and confirmed. Recombinant adenovirus Ad-UPII-E1A is effective in inhibition in bladder cancer cell line BIU-87.

AB - Aim: To construct urothelium-specific recombinant adenovirus and investigate its inhibition in bladder cancer cell. Methods: RT-PCR analysis was used to determine expression patterns of hUPII and coxsackie adenovirus receptor on multiple cell lines. Transient transfection and luciferase detecting assay were used to detect tissue specificity of the hUPII promoter. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed. Restrictive enzyme digestion assay and PCR confirmed the correct construction. The adenovirus E1A protein expressed in BIU-87 was tested by Western blot after cells were infected with recombinant adenovirus. Recombinant adenovirus Ad-UPII-E1A was tested for its inhibition in bladder cancer cell line BIU-87. Results: HUPII and CAR were expressed and the hUPII promoter is highly active in bladder cancer cell line BIU-87. Using homologous recombination in bacteria technology, the hUPII promoter and E1A gene were inserted into the genome of type 5 recombinant adenovirus. The E1A protein was markedly positive in the samples of BIU-87 cells infected with recombinant adenovirus Ad-UPII-E1A. MTT assay demonstrated recombinant adenovirus Ad-UPII-E1A inhibited bladder cancer cell BIU-87 growth. Conclusion: The hUPII promoter shows high tissue specificity. Recombinant adenovirus Ad-UPII-E1A and Ad-UPII-Null were constructed and confirmed. Recombinant adenovirus Ad-UPII-E1A is effective in inhibition in bladder cancer cell line BIU-87.

KW - Bladder cancer cell line

KW - Gene therapy

KW - Human uroplakin II

KW - Recombinant adenovirus

UR - http://www.scopus.com/inward/record.url?scp=63449084058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63449084058&partnerID=8YFLogxK

U2 - 10.1159/000200802

DO - 10.1159/000200802

M3 - Article

C2 - 19322012

AN - SCOPUS:63449084058

VL - 82

SP - 209

EP - 213

JO - Urologia Internationalis

JF - Urologia Internationalis

SN - 0042-1138

IS - 2

ER -